Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Innoventric is committed to expanding treatment beyond the traditionally treated patient population, extending care to the overlooked, ‘still forgotten’ patient population.

Content Locked
Login or Register a FREE account to continue browsing our content
2017
Ness Ziona, Israel
Israel

11 - 50
Series B| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Register for our free weekly newsletter
Stay up to date with the latest news, special reports, videos, infobytes, and features on the region's most notable entrepreneurial ecosystems